Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas

Exp Clin Endocrinol Diabetes. 2000;108(3):202-7. doi: 10.1055/s-2000-7887.

Abstract

Interleukins and their receptors are expressed intrinsically in the anterior pituitary and regulate hormone production and cell proliferation. It has previously been shown that interleukin-6 (IL-6) regulates hormone secretion in normal pituitary cells and cell lines. Here we examined the effects of IL-6 on propiomelanocortin (POMC) expression and ACTH production in corticotroph adenoma cells in vitro. We found that IL-6 stimulates both ACTH secretion and POMC gene expression in corticotroph adenoma cell cultures. This first demonstration of the stimulatory action of IL-6 on human corticotroph adenoma cell function provides further evidence for a direct action of IL-6 on corticotroph pituitary cells. We have confirmed previous reports of IL-6 production by corticotroph adenoma cells and in addition, demonstrated for the first time that the synthetic glucocorticoid dexamethasone is a potent suppressor of intratumoral IL-6 production. This intratumoral produced IL-6 may be in part responsible, in an autocrine manner, for the stimulation of ACTH synthesis and secretion. Our results suggest that IL-6 might play a role in the pathogenesis of Cushing's disease. However, elevated glucocorticoid levels in patients with Cushing's disease may prevent excessive action of IL-6 on ACTH production and tumor progression of corticotroph adenomas in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma / genetics
  • Adenoma / pathology
  • Adenoma / physiopathology*
  • Adenoma / surgery
  • Adrenocorticotropic Hormone / metabolism*
  • Adult
  • Cushing Syndrome / etiology
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Expression Regulation, Neoplastic / physiology*
  • Humans
  • Interleukin-6 / biosynthesis*
  • Interleukin-6 / pharmacology
  • Male
  • Middle Aged
  • Pituitary Neoplasms / genetics
  • Pituitary Neoplasms / pathology
  • Pituitary Neoplasms / physiopathology*
  • Pituitary Neoplasms / surgery
  • Pro-Opiomelanocortin / genetics*
  • RNA, Messenger / genetics
  • Recombinant Proteins / pharmacology
  • Transcription, Genetic / drug effects
  • Tumor Cells, Cultured

Substances

  • Interleukin-6
  • RNA, Messenger
  • Recombinant Proteins
  • Pro-Opiomelanocortin
  • Adrenocorticotropic Hormone